Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Diabetes Technology & Therapeutics|November 13, 2009
Safety and efficacy of inhaled human insulin (exubera) during discontinuation and readministration of therapy in adults with type 2 diabetes: a 3-year randomized controlled trialJulio Rosenstock, William T Cefalu, Priscilla A Hollander, et al.Journal of Pediatric Endocrinology & Metabolism : JPEM|August 23, 2008
Efficacy and safety of inhaled human insulin (Exubera) compared to subcutaneous insulin in children ages 6 to 11 years with type 1 diabetes mellitus: results of a 3-month, randomized, parallel trialNeil H White, Teresa Quattrin, Lisa B St Aubin, et al.Journal of Pediatric Endocrinology & Metabolism : JPEM|February 18, 2021
Efficacy and Safety of Inhaled Human Insulin (Exu hera<sup>®</sup>) Compared to Subcutaneous Insulin in Children Ages 6 to 11 Years with Type 1 Diabetes Mellitus: Results of a 3-Month, Randomized, Parallel TrialNeil H White, Teresa Quattrin, Lisa B St Aubin, et al.Contemporary Clinical Trials Communications|June 2, 2020
Pulmonary and cardiovascular safety of inhaled insulin in routine practice: The Exubera Large Simple Trial (VOLUME)Nicolle M Gatto, Michael B Bracken, Francesca Kolitsopoulos, et al.Diabetes Care|July 24, 2019
Lung Cancer-Related Mortality With Inhaled Insulin or a Comparator: Follow-Up Study of patients previously enrolled in Exubera Controlled Clinical Trials (FUSE) Final ResultsNicolle M Gatto, Daniel O Koralek, Michael B Bracken, et al.Journal of Lipid Research|September 4, 2012
Relationship between atorvastatin dose and the harm caused by torcetrapibPhilip J Barter, Kerry-Anne Rye, Mohan S Beltangady, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2021
The Effect of Corticosteroids on Prostate Cancer Outcome Following Treatment with Enzalutamide: A Multivariate Analysis of the Phase III AFFIRM TrialJimmy L Zhao, Karim Fizazi, Fred Saad, et al.Diabetes Care|June 7, 2008
Two-year pulmonary safety and efficacy of inhaled human insulin (Exubera) in adult patients with type 2 diabetesJulio Rosenstock, William T Cefalu, Priscilla A Hollander, et al.The New England Journal of Medicine|March 28, 2007
Effect of torcetrapib on the progression of coronary atherosclerosisSteven E Nissen, Jean-Claude Tardif, Stephen J Nicholls, et al.American Journal of Respiratory and Critical Care Medicine|May 10, 2008
Intersession variability in single-breath diffusing capacity in diabetics without overt lung diseaseMichael B Drummond, Pamela F Schwartz, William T Duggan, et al.Pageof 2